GSRF
NASDAQ · N/A
Gsr Iv Acquisition Corp-Cl A
$10.03
-0.01 (-0.10%)
Open$10.02
Previous Close$10.04
Day High$10.03
Day Low$10.02
52W High$18.08
52W Low$7.68
Volume—
Avg Volume786.1K
Market Cap294.94M
P/E Ratio—
EPS$-1.33
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 146.09M | 153.79M | 147.45M |
| Net Income | 10.19M | 14.28M | 11.11M |
| Profit Margin | 7.0% | 9.3% | 7.5% |
| EBITDA | 17.65M | 19.50M | 17.14M |
| Free Cash Flow | 14.65M | 14.16M | 16.41M |
| Rev Growth | +20.6% | +16.4% | -5.4% |
| Debt/Equity | 0.07 | 0.10 | 0.08 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |